Connection

Piercarlo Sarzi-Puttini to Registries

Back to Details
This is a "connection" page, showing publications Piercarlo Sarzi-Puttini has written about Registries.
Piercarlo Sarzi-Puttini
Connection Strength
0.104
Registries
  1. Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry. Clin Exp Rheumatol. 2017 Sep-Oct; 35(5):804-809.
    View in: PubMed
    Score: 0.041
  2. Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries. Clin Exp Rheumatol. 2017 Jul-Aug; 35(4):660-665.
    View in: PubMed
    Score: 0.041
  3. Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEA. Clin Exp Rheumatol. 2019 Jul-Aug; 37(4):649-655.
    View in: PubMed
    Score: 0.012
  4. Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry. Clin Rheumatol. 2017 Apr; 36(4):753-761.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.